Vericel Corp. (VCEL)
33.70
+0.11
(+0.33%)
USD |
NASDAQ |
Apr 10, 16:00
33.71
+0.01
(+0.03%)
After-Hours: 20:00
Vericel Shareholders Equity (Quarterly) : 354.64M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Arbutus Biopharma Corp. | 76.58M |
| Marker Therapeutics, Inc. | 16.80M |
| Moderna, Inc. | 8.65B |
| Krystal Biotech, Inc. | 1.220B |
| Tenaya Therapeutics, Inc. | 123.26M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 487.97M |
| Total Liabilities (Quarterly) | 133.33M |
| Debt to Equity Ratio | 0.2771 |
| Current Ratio | 5.034 |
| Net Debt Paydown Yield | -0.01% |